scholarly journals Patient, doctor, disease, and informed consent

2011 ◽  
Vol 6 ◽  
Author(s):  
Riccardo Pela

Lung cancer is the 10th ranking cause of death in the world: its incidence has reached a steady state in the male gender while it is still increasing in fe- males. Even if data are now available on lung can- cer screening with low-dose spiral computerized tomography [...]






CHEST Journal ◽  
2019 ◽  
Vol 156 (4) ◽  
pp. A1732
Author(s):  
Mayuko Fukunaga ◽  
FCCP ◽  
Kyle Halligan ◽  
Jennifer Kodela ◽  
Shaun Toomey ◽  
...  


Author(s):  
Hamid Ghaznavi ◽  
Farideh Elahimanesh ◽  
Jamil Abdolmohammadi ◽  
Meysam Mirzaie ◽  
Sadegh Ghaderi

Abstract Background: The Coronavirus disease 2019 (COVID-19) is spreading rapidly throughout the world. Lung is the primary organ which the COVID-19 virus affects and leads to pneumonia, an acute respiratory distress syndrome. COVID-19 infects the lower respiratory system, and the lung’s response to this infection is recruiting macrophages and monocytes leading to inflammation, this response causes widespread damage to the lung’s airways. Aim: The purpose of this study is to review studies of using low-dose radiation as a treatment for the inflammation of the tissue and pneumonia resulting from COVID-19. These studies were compared with the risk of developing lung cancer during performed dose for the treatment of COVID-19 in radiation therapy. Materials and methods: Our study focused on in vitro, in vivo and clinical reports of using low-dose radiation for the treatment of inflammation, pneumonia and COVID-19. The risk of lung cancer resulting from suggested dose in these studies was also evaluated. Conclusion: From the review of articles, we have found that low-dose radiation can lead to improvement in inflammation in different line cells and animals; in addition, it has been effective in treating inflammation and pneumonia caused by COVID-19 in human up to 80%. Since suggested doses do not remarkably increase the lung cancer risk, low-dose radiation can be an adjuvant treatment for COVID-19 patients.



2008 ◽  
Vol 2 (4) ◽  
pp. 193-203
Author(s):  
Matteo Giaj Levra ◽  
Marina Longo ◽  
Enrica Capelletto ◽  
Simonetta Grazia Rapetti ◽  
Silvia Novello

Lung cancer is the main cause of death for neoplasia in the world. Hence it’s growing the necessity to investigate screening tests to detect tumoral lesions at the early stages: several trials have been performed to establish the best method, target and frequence of the screening to offer. CT, X-ray, PET, sputum citology and CAD software are here analyzed, together with the associated statistics and bias.



2018 ◽  
Vol 108 (10) ◽  
pp. 1296-1302 ◽  
Author(s):  
Steven B. Markowitz ◽  
Amy Manowitz ◽  
Jeffery A. Miller ◽  
James S. Frederick ◽  
Amaka C. Onyekelu-Eze ◽  
...  


2016 ◽  
Vol 9 (1) ◽  
pp. 3 ◽  
Author(s):  
Tibor Krajc ◽  
BeatriceAlexandra Marzluf ◽  
MichaelRolf Mueller


2019 ◽  
Vol 14 (3) ◽  
pp. 436-444 ◽  
Author(s):  
Hye-Rin Kang ◽  
Jun Yeun Cho ◽  
Sang Hoon Lee ◽  
Yeon Joo Lee ◽  
Jong Sun Park ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document